66. IgA腎症 ［臨床試験数：199，薬物数：214（DrugBank：57），標的遺伝子数：32，標的パスウェイ数：128］
Searched query = "IgA nephropathy", "IgA nephritis", "Berger disease", "IgA-IgG nephropathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||EUCTR2005-003885-40-IT||18/10/2005||15/01/2007||ACE-inhibitors and Angiotensin two receptor antagonists in IgA nephropathy with mild proteinuria -||The primary aim of the study consists in testing the hypothesis that blockade of the RAS may decrease the risk of developing adverse effects in patients with benign IgAN.Such blockade would first achieved with unique pharmacological class then shifting to the association of the two classes as soon as ineffective blockade is documented |
MedDRA version: 9.1Level: SOCClassification code 10038359Term: Renal and urinary disorders
|Product Name: Ramipril|
INN or Proposed INN: Ramipril
Product Name: Irbesartan
INN or Proposed INN: Irbesartan
|AZIENDA OSPEDALIERA PROVINCIALE DI LECCO||NULL||Not Recruiting||Female: yes|
|2||ChiCTR-TRC-09000630||2004-01-01||2005-09-06||Treatment of Early Immunoglobulin A Nephropathy by the Angiotensin Converting Enzyme Inhibitor Ramipril - A Randomized Controlled Trial||Treatment of Early Immunoglobulin A Nephropathy by the Angiotensin Converting Enzyme Inhibitor Ramipril - A Randomized Controlled Trial||IgA nephropathy||Two groups:ramipril 5 years versus no treatment;||The Chinese University of Hong Kong||NULL||Recruiting||0||0||Male||Two groups:60;||China|
|3||NCT01225445||April 2002||20/10/2010||Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial||Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial||Biopsy-confirmed IgA Nephropathy;Proteinuria Less Than 0.5 g Per Day;Normal Blood Pressure;Serum Creatinine Below 120 Umol/l||Drug: Ramipril||Chinese University of Hong Kong||NULL||Completed||18 Years||25 Years||Both||60||Phase 3||Hong Kong|